Month: January 2024

Takeda_Logo-2

Takeda’s HYQVIA® Approved by European Commission as Maintenance Therapy in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

HYQVIA becomes the Only Facilitated Subcutaneous Immunoglobulin, Offering Patients an up to Once-Monthly Treatment Option At-Home or In-Office Administration Provides...

RiesterLogo_solid_blue_rgb

Rudolf Riester GmbH Announces Global Market Launch of Telemedicine Solution, Showcases ri-sonic® E-Stethoscope + eMurmur® AI Integration for Heart Murmur Detection at Arab Health 2024

Offering Free Heart Checks to Mark 75 Years of Excellence in Healthcare Innovation JUNGINGEN, Germany--(BUSINESS WIRE)--Rudolf Riester GmbH, a global...